4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro-

Modify Date: 2024-01-05 18:34:32

4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro- Structure
4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro- structure
Common Name 4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro-
CAS Number 5334-23-6 Molecular Weight 152.17700
Density N/A Boiling Point 386.8ºC at 760 mmHg
Molecular Formula C5H4N4S Melting Point 300ºC
MSDS N/A Flash Point 187.7ºC

 Names

Name 4-Mercaptopyrazolo[3,4-d]pyrimidine
Synonym More Synonyms

 Chemical & Physical Properties

Boiling Point 386.8ºC at 760 mmHg
Melting Point 300ºC
Molecular Formula C5H4N4S
Molecular Weight 152.17700
Flash Point 187.7ºC
Exact Mass 152.01600
PSA 93.26000
LogP 0.64160

 MSDS

Name: 4-Mercapto-1H-Pyrazolo(3 4-D)Pyrimidine Hemihydrate 99% Material Safety Data Sheet
Synonym: 1H-Pyrazolo[3,4-D]Pyrimidine-4-Thiol Hemihydrat
CAS: 5334-23-6
Section 1 - Chemical Product MSDS Name:4-Mercapto-1H-Pyrazolo(3 4-D)Pyrimidine Hemihydrate 99% Material Safety Data Sheet
Synonym:1H-Pyrazolo[3,4-D]Pyrimidine-4-Thiol Hemihydrat

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
5334-23-6 4-Mercapto-1H-Pyrazolo(3,4-D)Pyrimidin 99 226-251-8
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this material have not been fully investigated.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 5334-23-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: > 300 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C5H4N4S
Molecular Weight: 152.17

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 5334-23-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Mercapto-1H-Pyrazolo(3,4-D)Pyrimidine Hemihydrate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 5334-23-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 5334-23-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5334-23-6 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 Safety Information

Risk Phrases 36/37/38
Safety Phrases S24/25
HS Code 2933990090

 Synthetic Route

~98%

4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro- Structure

4H-Pyrazolo[3,4...

CAS#:5334-23-6

Literature: Moukha-Chafiq; Taha; Lazrek; Pannecouque; Witvrouw; De Clercq; Barascut; Imbach Nucleosides, Nucleotides and Nucleic Acids, 2001 , vol. 20, # 10-11 p. 1797 - 1810

~%

4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro- Structure

4H-Pyrazolo[3,4...

CAS#:5334-23-6

Literature: Journal of the American Chemical Society, , vol. 78, p. 784,787 Journal of the American Chemical Society, , vol. 79, p. 6407,6413

 Customs

HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 Synonyms

4-Mercapto-1H-Pyrazolo[3,4-d]Pyrimidine
1,2-dihydropyrazolo[3,4-d]pyrimidine-4-thione
EINECS 226-251-8
MFCD00005687
Top Suppliers:I want be here



Get all suppliers and price by the below link:

4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro- suppliers

4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro- price

Related Compounds: More...
4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro-6-methyl-
15986-11-5
4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro-3-methyl-
2942-48-5
4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro-3-methyl-1-phenyl-
14246-99-2
4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro-6-methyl-1-(4-nitrophenyl)-
5399-42-8
4H-Pyrazolo[3,4-d]pyrimidine-4-thione,1,5-dihydro-3-methyl-1-phenyl-6-(trifluoromethyl)
102989-83-3
5-amino-6-anilino-1H-pyrazolo[3,4-d]pyrimidine-4-thione
141300-25-6
5-amino-6-(4-chloroanilino)-1H-pyrazolo[3,4-d]pyrimidine-4-thione
141300-26-7
4H-Pyrazolo[3,4-d]pyrimidine-4-thione,6-(4-aminophenyl)-1,5-dihydro-
15986-13-7
9-phenyl-2,4,8,9-tetrazabicyclo[4.3.0]nona-1,3,6-triene-5-thione
6014-07-9
4-(6-{4-[3-(Trifluoromethyl)pyridin-2-yl]piperazin-1-yl}pyridazin-3-yl)morpholine
2549029-98-1
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
4-((3-Ethynyl-5-methylphenoxy)methyl)tetrahydro-2H-pyran
2809953-74-8
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
4-{[4-({Imidazo[1,2-b]pyridazin-6-yloxy}methyl)piperidin-1-yl]sulfonyl}benzonitrile
2548994-20-1
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
3-(3,5-dimethyl-1H-pyrazol-1-yl)-6-{4-[(pyridin-3-yl)methyl]piperazin-1-yl}pyridazine
2548995-08-8
N-[(2-Pyridin-2-ylphenyl)methyl]propan-2-amine;dihydrochloride
2460749-02-2